Amanda Shevanthi Nayagam

Imperial College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Jack Cafferkey

ECAT Clinical Lecturer

UNITED KINGDOM

View details

Peter Crook

Honorary Clinical Lecturer

City St George's University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amanda Shevanthi Nayagam

Research Interests

Explore related searches

Contact this professor

Articles (20)

Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study

Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study

TREAT-B or Treat All: time for a broader vision on hepatitis B elimination – Author's reply

TREAT-B or Treat All: time for a broader vision on hepatitis B elimination - Author's reply.

Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis

Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis

Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia

Global reporting of progress towards elimination of hepatitis B and hepatitis C

Global reporting of progress towards elimination of hepatitis B and hepatitis C.

Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study

Status of the HIV epidemic in Manicaland, east Zimbabwe prior to the outbreak of the COVID-19 pandemic

Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning

Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models

Adapting hospital capacity to meet changing demands during the COVID-19 pandemic

Cost-effectiveness of strategies to improve HCV screening, linkage-to-care and treatment in remand prison settings in England

Factors associated with reattendance to emergency services following COVID-19 hospitalization

In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19

Letter: liver disease and COVID-19—not the perfect storm

Collaborators (2)

Jack Cafferkey

Peter Crook

Make your next move.